Bukit Uluwatu Villa Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Bukit Uluwatu Villa Tbk trades at Rp850 (market cap 20.56T, 174.7M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: Bukit Uluwatu Villa Tbk is far larger — about 35.2× UBC Medical Indonesia Tbk.'s market cap, and Bukit Uluwatu Villa Tbk is more actively traded (174.7M versus 817.3K). Which is the better fit depends on your goals.
| BUVA | LABS | |
|---|---|---|
Market Cap | 20.56T | 584.6B |
Volume | 174.7M | 817.3K |
Lot | 1.75M | 8.17K |
Turnover | 149.55B | 120.01M |
Average Price | 856.05 | 146.84 |
Value | 149.55B | 120.01M |
Indicative Equilibrium Price | 850 | 146 |
Indicative Equilibrium Volume | 79.05K | 59 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bukit Uluwatu Villa Tbk (the “Company”) was established in the Republic of Indonesia on December 15, 2000 based on the Notarial Deed No. 53 of Sugito Tedjamulja, S.H.. The Company’s status has been changed from foreign investment company (PMA) to domestic investment company (PMDN).
Read more on BUVA →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →